M Nagano Selected Research

M Nagano Research Topics

2	Type 2 Diabetes Mellitus (MODY) 05/2004 - 01/2004
1	Virus Diseases (Viral Diseases) 09/2019
1	Body Weight (Weight, Body) 12/2010
1	Neuralgia (Stump Neuralgia) 11/2008
1	Pain (Aches) 11/2008
1	Glucose Intolerance 05/2004
1	Insulin Resistance 01/2004
1	Diabetes Mellitus 01/2004
1	Obesity 01/2004
1	Arsenic Poisoning 12/2001
1	Skin Manifestations 12/2001
1	Hypersensitivity (Allergy) 10/2001
1	Atherosclerosis 06/2001
1	Neoplasms (Cancer) 02/2001
1	Alzheimer Disease (Alzheimer's Disease) 11/2000
1	Autolysis 06/2000
1	Nervous System Mercury Poisoning (Minamata Disease) 06/2000
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2000
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 05/2000
1	Myocardial Infarction 01/2000
1	Coronary Occlusion 01/2000
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2000

2	Messenger RNA (mRNA)IBA 11/2008 - 06/2000
2	Cholesterol Ester Transfer ProteinsIBA 01/2004 - 06/2001
1	IceIBA 09/2019
1	AntralIBA 12/2010
1	Tachykinin Receptors (Tachykinin Receptor)IBA 11/2008
1	Minocycline (Cyclops)FDA LinkGeneric 11/2008
1	hemokinin-1IBA 11/2008
1	LipidsIBA 01/2004
1	Phospholipid Transfer ProteinsIBA 01/2004
1	lipid transfer protein (glycolipid transfer protein)IBA 01/2004
1	Triglycerides (Triacylglycerol)IBA 01/2004
1	ArsenicIBA 12/2001
1	CollagenIBA 10/2001
1	Lipoproteins (Lipoprotein)IBA 06/2001
1	Cholesterol Esters (Cholesteryl Esters)IBA 06/2001
1	CholesterolIBA 06/2001
1	Apolipoproteins B (ApoB)IBA 06/2001
1	ApolipoproteinsIBA 06/2001
1	CS 932IBA 11/2000
1	Nootropic Agents (Nootropics)IBA 11/2000
1	MercuryIBA 06/2000
1	E 25 (E-25)IBA 01/2000
1	Polyvinyl Chloride (PVC)IBA 01/2000
1	Vitamin E FDA LinkGeneric 01/2000
1	AntioxidantsIBA 01/2000